The risks of meeting SLICC
chronic cutaneous criteria and SLICC
Damage Index skin damage criteria rose in a linear fashion with the number of pack-years of smoking.
The efficacy and safety of ustekinumab was evaluated in a global Phase 2, randomised, placebo-controlled trial in 102 adults with seropositive SLE by Systemic Lupus International Collaborating Clinics (SLICC
) criteria and active disease despite ongoing standard of care therapy (steroid, antimalarial and/or immunosuppressive therapies) (NCT no.
Association of sTLT-1 levels with disease activity, damage accrual and patient reported outcomes Feature Correlation with sTLT-1 levels r p SLAM-R -0.278 0.064 SDI 0.002 0.991 LupusPRO domains Lupus symptoms -0.388 0.055 Cognition -0.442 0.027 Lupus medications -0.313 0.128 Procreation -0.071 0.736 Physical health -0.382 0.060 Pain vitality -0.300 0.145 Emotional health -0.294 0.154 Body image -0.153 0.467 Desires/goals +0.435 0.030 Social support -0.224 0.282 Coping -0.319 0.121 Satisfaction with care -0.191 0.361 SLAM-R: Systemic Lupus Activity Measure-Revised; SDI: Systemic Lupus International Collaborating Clinics (SLICC
) Damage Index; LupusPRO: Lupus Patient-Reported Outcome
For example, HCQ was protective (HR 0.73; 95%CI 0.52 to 1.00) against damage accrual, calculated using the SLICC
damage index, in the prospective LUMINA (Lupus in Minorities: nature versus nurture) study cohort, particularly in those patients without damage at baseline (HR 0.55, 95%CI 0.34 to 0.87) (94).
KEY WORDS: Systemic Lupus International Collaborating Clinics (SLICC
), Systemic Lupus Erythematosus (SLE), Cognitive dysfunction, Montreal Cognitive Assessment (MoCA).
Here we report a case of ANA-negative SLE that fulfilled 9/17 of SLICC
criteria and 5/11 of ACR criteria, presenting as profound autoimmune neutropenia with strongly positive anti-neutrophil antibodies.
Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC
) Inception Co hort.
 According to the 2012 Systemic Lupus International Collaborating Clinics Classification (SLICC
) criteria for the diagnosis of SLE, kidney disease is present when a patient with SLE presents with persistent proteinuria (> 0.5 g/24 h) or cellular red cell casts.
The diagnosis is confirmed also using the revised SLICC
Classification Criteria for systemic lupus erythematosus (2012, revised in 2015).
However, our patient met the ACR criteria for SLE (which has a sensitivity of 85% and specificity of 95%11) as he had arthralgias, pleural and pericardial effusions, lymphopenia and raised anti-dsDNA, and met 5 out of 11 criteria according to newer Systemic Lupus International Collaboration Clinics Criteria (SLICC
criteria) due to decreased complement levels.12
New guidelines to diagnose lupus have been recently published by the Systemic Lupus International Collaboration Clinics (SLICC